Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia.
about
Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis.Plasma exchange in Canada. The Canadian Apheresis Study GroupAtherosclerosis. I. A leiomyoproliferative disease of the arteries resulting from breakdown of the endothelial barrier to potent blood growth factors. II. Perspectives in atheroprophylaxis.Clinical experience and future directions for low-density lipoprotein apheresis in the United States.Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia.Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.Preparation of new amphiphilic macroporous nonwoven polymeric adsorbents aimed for selective removal of low-density lipoprotein from plasma.Low-density lipoprotein apheresis: an overview.Plasma high density lipoprotein is increased in man when low density lipoprotein (LDL) is lowered by LDL-pheresis.Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and ManagementCurrent view: indications for extracorporeal lipid apheresis treatment.Enzymatic modification of plasma low density lipoproteins in rabbits: a potential treatment for hypercholesterolemiaTreatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool sizesQuantitative removal of hepatitis B viral antigens from serum by a monoclonal IgM coupled to a biocompatible solid-phase support.The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.Lipid apheresis, indications, and principles.Conventional apheresis therapies: a review.Low-density lipoprotein apheresis: principles and indications.Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.Lipoprotein apheresis to treat elevated lipoprotein (a)Role of lipid apheresis in changing times.Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.The Italian Consensus Conferences on low density lipoprotein-cholesterol apheresis.Polyacrylate adsorbents for the selective adsorption of cholesterol-rich lipoproteins from plasma or blood.The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concenPlasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia.Cellulose amphiphilic adsorbent for the removal of low density lipoprotein.A newly developed LDL-binding material.Synthesis and in vitro sorption properties of PAA-grafted cellulose beads for selective binding of LDL.Brief history of low-density lipoprotein apheresis.Is there a place for LDL-apheresis in the management of raised cholesterol?
P2860
Q33392466-788A5C8F-788C-4B63-818A-19B36B27F2A6Q33396347-29702E02-0ECC-4CAA-B4E9-237B7A5F09B9Q33445200-AA8E5A1B-5A25-483A-87BE-E9AE5CC28AE5Q33606749-487C67C5-D1DC-461A-9342-EE447C90E616Q34238659-9C80D694-B32B-4039-95E0-1312C047F965Q34492190-F9DCDE8A-ECDF-439D-984C-9129E3FC7D8CQ35157272-7375086F-9D5E-4505-9AC4-F33AB5F1B3AAQ35187604-6DBF3B15-F812-4F80-AD63-125222591A97Q35589058-57391B7E-467B-4481-82F2-786847DC6127Q35756629-0F300AFE-6EF8-47FE-8AB8-F3B90E436E24Q36028650-B9772733-AEFD-4667-BBF8-EC934541BEEAQ36246442-D483DD6F-AEA3-4B5E-A689-DF9A10943DFCQ37602264-5E25A773-EB89-4396-B451-64EDCD4078FDQ37615617-9E75EC42-9841-44D9-B519-016A1D10E043Q37703258-368F512D-53C0-497F-B0EE-B00A468FFAEDQ37915431-36A1FAE6-AF86-4F34-AA2E-435BC37DB691Q37924701-79DB25F3-BFB9-426C-98E8-D27C79B22577Q37978674-B8644467-1FC6-4BE0-8A56-F03A0444119DQ38269605-9F652493-5345-46A2-A809-3D3F2DF20F3CQ38738379-0C40D909-02FD-4766-8F70-8CB6992761F4Q39548527-383D50DC-367C-4FED-B667-1B0D91FAD2FAQ41208752-B9292338-2381-43D3-BAED-A2CAC2DC9484Q42327839-BB4958B5-BC5F-42DF-8BB1-C4C918A30EAFQ42582834-382054C8-1379-4C48-828D-F058357357F1Q42691666-2A2929B1-2584-4D9C-BA53-A6E19172A7E2Q43817902-BF13486A-DE7E-4133-AAC4-BD04768CE505Q44134682-5E995936-CCA8-4649-9F70-DEBE7732792CQ44317978-681EB618-407C-4CC4-AB14-C51158E29AECQ51150124-3C585667-6369-4DE4-8A06-5E660506A910Q53378633-0AFB1DC2-9E4C-4D19-BAB2-D17FF21B8E41Q57382556-BB283667-DE61-4974-BF73-20F57BD07589
P2860
Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia.
description
1981 nî lūn-bûn
@nan
1981 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Application of specific extrac ...... amilial hypercholesterolaemia.
@ast
Application of specific extrac ...... amilial hypercholesterolaemia.
@en
Application of specific extrac ...... amilial hypercholesterolaemia.
@nl
type
label
Application of specific extrac ...... amilial hypercholesterolaemia.
@ast
Application of specific extrac ...... amilial hypercholesterolaemia.
@en
Application of specific extrac ...... amilial hypercholesterolaemia.
@nl
prefLabel
Application of specific extrac ...... amilial hypercholesterolaemia.
@ast
Application of specific extrac ...... amilial hypercholesterolaemia.
@en
Application of specific extrac ...... amilial hypercholesterolaemia.
@nl
P2093
P1433
P1476
Application of specific extrac ...... amilial hypercholesterolaemia.
@en
P2093
P304
P356
10.1016/S0140-6736(81)91213-7
P407
P577
1981-11-01T00:00:00Z